Anti-Cetuximab Polyclonal Antibody|抗西妥昔单抗多克隆抗体(靶标：西妥昔单抗（抗EGFR单抗）)
- 货号：RB9TAF004014
- 价格：面议
- 点击：173
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA |
| 特异性 | The product is specific for Cetuximab. This antibody serves as an excellent positive control for Cetuximab immunogenicity (ADA) assays. |
| 靶标 | Rabbit polyclonal to Erbitux. |
| 免疫原 | Cetuximab |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 稳定性和储存 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | CAS: 205923-56-4 |
| 背景信息 | Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR. • Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies., PMID:36408164 • Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy., PMID:21255939 |
| 备注 | For research use only. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 痢疾志贺氏菌单克隆抗体 | 7516 |
| 沙门氏菌单克隆抗体 | 7294 |
| 乙型副伤寒沙门氏菌单克隆抗体 | 7874 |
| A族链球菌单克隆抗体 | 7434 |
| 甲型副伤寒沙门氏菌单抗 | 7241 |
| 麻疹病毒单克隆抗体 | 7469 |
| HBeAg单克隆抗体 | 7442 |
| 新型冠状病毒（SARS-COV-2）NP蛋白单克隆抗体 | 6941 |
| 呼吸道腺病毒单克隆抗体 | 7635 |
| 大肠杆菌单克隆抗体 | 7554 |
| LP-PLA2单克隆抗体 | 7501 |
| NT-PROBNP单克隆抗体 | 7271 |
| 半乳糖凝集素3单克隆抗体 | 7230 |
| D二聚体单克隆抗体 | 7208 |
| 肌钙蛋白单克隆抗体 | 7558 |
| 肌红蛋白单克隆抗体 | 7427 |
| AAT单克隆抗体 | 7213 |
| 人SAA单克隆抗体 | 7195 |
| 黏病毒抗性蛋白A单克隆抗体 | 7422 |
| 降钙素原单克隆抗体 | 7112 |